Market study • Edition 2026
The obesity market in France
Market size, players, trends and sourced figures for your business plan, your bank file or your competitive analysis.
- The market: 18.1% of adults obese in 2024, GLP-1 RAs, reimbursement and surgery
- The players: Eli Lilly, Novo Nordisk, pharmacies, specialist centres, surgeons…
- The issues: reimbursement of Wegovy and Mounjaro, cost of care, care pathways
Exclusive sources: trade press with more than 500 journals and 3,000 new articles a month, not available in open access. Every cited article can be read.
The obesity market in France
€99 incl. VAT€93.84 excl. VAT
Request the study Read the study View the previewKey figures of the obesity market in France
The obesity market in France concerns 18.1% of adults in 2024, or nearly 10 million people, according to the Ligue contre l’obésité’s Oféo survey. It brings together GLP-1 receptor agonists, bariatric surgery and nutritional follow-up, with treatments such as Wegovy and Mounjaro and pharmaceutical companies such as Eli Lilly. Wegovy and Mounjaro have been reimbursed at 65% since 15 June 2026 for severe obesity, subject to conditions.
- Share of adults living with obesity, i.e. nearly 10 million people
- 18.1%
- 2024 • Source: Ligue contre l’obésité (the French obesity league), Oféo survey
- Patients treated with a GLP-1 RA, all indications combined
- 840,000
- February 2025 to January 2026 • Source: ANSM (the French medicines agency)
- Reimbursement of Wegovy and Mounjaro in severe obesity, under conditions
- 65%
- Since 15 June 2026 • Source: Service-public.fr (the French public administration portal)
- Estimated annual cost of the reimbursement once fully rolled out
- €100m
- 2026 estimate • Source: French Ministry of Health, as reported by Caducee.net
- People potentially concerned by this reimbursement, at most
- 1 million
- 2026 • Source: French Ministry of Health, as reported by Caducee.net
- Bariatric surgery procedures a year, versus 59,300 in 2016
- 30,000
- 2026 / 2016 • Source: Le Quotidien du médecin; Drees (the French health statistics office)
The obesity market in France in 6 questions
Our analysts’ answers, taken from the study. The full analysis, the charts and the detailed sources are in the report.
How big is the obesity market in France?
Are obesity drugs reimbursed in France?
How much do obesity treatments cost in France?
Who are the main players in the obesity market in France?
Is obesity surgery declining in France?
Which regions are most affected by obesity in France?
Sources: Ligue contre l’obésité, Oféo survey, 2024 • ANSM, GLP-1 RA pharmacovigilance report, October 2026 • Service-public.fr, June 2026 • Drees, Études et résultats no. 1051, 2018 • Le Quotidien du médecin, 2024 and 2026 • Caducee.net, May 2026 • Sud Radio, August 2026 • Trade press (IndexPresse database)


Browse an excerpt before you buy
A free excerpt of the study: judge the writing, the figures and the sources for yourself.
In the preview
- The purpose of the study and its key figures
- The complete table of contents
- The layout of the charts and sources
Study contents
Browse the chapters to identify the analyses relevant to your project.
- Understand customers and uses
- Connect products, businesses and distribution channels
- Compare market participants and their models
1. Obesity: definition and market scope
2. Market size and dynamics
3. Patients and demand
4. Treatments and their supply
5. The players
6. Regulation and outlook
Why a Businesscoot study
Three ways to answer the same question about a market, compared line by line.
| General-purpose AIA draft to verify | Traditional research firmThorough, but costly | Businesscoot studyComplete and affordable |
|---|---|---|
| FiguresCited links, variable reliability | FiguresOwn sources and estimates | FiguresSource and period for every figure |
| Professional pressOutside the public web | Professional pressVaries by firm | Professional press500+ paid journalsIndexPresse database |
| ScopeTo restate with every question | ScopeDefined | ScopeFrench market, clearly bounded |
| ContentGeneral answers, to cross-check | ContentTailored to the brief | ContentSize, players, trends, forecasts |
| DeliverableText to format | Deliverable150 to 300 pages | DeliverableStructured file with charts |
| Your timeInstant answer | Your timeLong to digest | Your timeReady to read |
| CostFree or subscription | CostAbout €1,000 to €3,000 excl. VAT | Cost€99 incl. VAT |
General-purpose AI
A draft to verify
- Figures
- Cited links, variable reliability
- Professional press
- Outside the public web
- Scope
- To restate with every question
- Content
- General answers, to cross-check
- Deliverable
- Text to format
- Your time
- Instant answer
- Cost
- Free or subscription
Traditional research firm
Thorough, but costly
- Figures
- Own sources and estimates
- Professional press
- Varies by firm
- Scope
- Defined
- Content
- Tailored to the brief
- Deliverable
- 150 to 300 pages
- Your time
- Long to digest
- Cost
- About €1,000 to €3,000 excl. VAT
Businesscoot study
Complete and affordable
- Figures
- Source and period for every figure
- Professional press
- 500+ paid journalsIndexPresse database
- Scope
- French market, clearly bounded
- Content
- Size, players, trends, forecasts
- Deliverable
- Structured file with charts
- Your time
- Ready to read
- Cost
- €99 incl. VAT
They bought our studies
Reviews collected after purchase and published as written, in French.
- studies sold since 2009
- 43,000+
- customers trust us
- 21,000+
- of market studies
- 17 years
- of IndexPresse press
- 35 years
« Etude pertinente avec un rapport qualité prix absolument imbattable. Idéal pour dossier bancaire ou rachat de société. Je recommande. »Mathieu Petit • Agence Felix
Le marché du karting
« Ces études de marché sont une très bonne synthèse pour tout professionnel qui souhaite gagner du temps. »
Paul Grasset
Le marché du linge de maison
« Etude claire, synthétique et bien structurée (agréable à lire et facile à en tirer la substance souhaitée). »
Sébastien Menand
Le marché du thé
« Étude de marché très précise et documentée, notamment sur les sous-segments de ce marché. »
Jean-Philippe Aboab • Pharmefficare
Le marché de la garde d’enfants
How the study is built
In-house analysts, professional sources and figures checked against their original publication.
- 17 years of market studies
- 35 years of professional press
- Sources you can open
01
Define
The market is defined before it is measured: products, channels, geographic area. Every figure covers that same scope.
02
Source
Public statistics, professional bodies and more than 500 paid trade journals from the IndexPresse database.
03
Cross-check
Every figure is matched with its original publication and dated. From the study, you can trace each one back to its source.
04
Update
When you order, one of our analysts updates the study with the latest published figures. You receive it within 48 hours.

Guilhem Cournut
Food, retail and consumer goods

Denis Monnoyeur
Industry, energy and construction

Marie-Annick Cournède
Health, beauty and personal services

Arthur Lefeuvre
Digital, media and telecommunications
Frequently asked questions
Quick answers about the market, the study and your order.
How big is the obesity market in France?
What does the study contain and in what format?
What sources does the study rely on?
Is the data up to date?
Who is this study for?
When and how will I receive the study?
How is it different from a Google search or an AI?
Can I get an invoice, pay by bank transfer or ask for a quote?
What if the study does not match what is announced?
I need several studies: is there a better price?
Order the study
This study
Updated for 2026The obesity market in France
€99incl. VAT • €93.84 excl. VAT
- PDF, 29 figures and 49 pages, 2026 edition
- Updated when you order, sent by email
- Invoice with VAT
- 4.5/5 from 827 reviews



Several markets to study
The 3-study pack
€240incl. VAT • €80 per study
The 5-study pack
€350incl. VAT • €70 per study
The Businesscoot subscription
On quoteunlimited access
- 3 studies of your choice in the catalogue
- To use within 12 months
- No subscription or renewal
- One invoice with VAT
- 5 studies of your choice in the catalogue
- To use within 12 months
- No subscription or renewal
- One invoice with VAT
- Every study in the catalogue, unlimited
- Price and term set on quote
- A talk with the team before any commitment
- One invoice with VAT
Related studies
Explore complementary studies to broaden your analysis.
- Explore related markets
- Compare market dynamics
- Refine your project
The immuno-oncology market in France
In 2024, 82% of the €5.6bn of cancer drugs billed on top of hospital tariffs in France are immunotherapies, about €4.6bn.
The general practitioners and specialist doctors market in France
In 2025, community care by general practitioners and specialists reaches €23.9bn in France, while 47% of practising doctors are salaried.
The mental health market in France
In 2024, the French health insurance system (Assurance maladie) reimbursed €29.1bn for psychiatric illness and psychotropic drugs, or 13.7% of its spending.
See also: The pain management market in France • The hydroponics market in France • The contract clinical research market in France • The medically assisted reproduction market in France • France gene therapy market



